Abstract
The atrioventricular canal (AVC) is the site where key structures responsible for functional division between heart regions are established, most importantly, the atrioventricular (AV) conduction system and cardiac valves. To elucidate the mechanism underlying AVC development and function, we utilized transgenic zebrafish line sqet31Et expressing EGFP in the AVC to isolate this cell population and profile its transcriptome at 48 and 72 hpf. The zebrafish AVC transcriptome exhibits hallmarks of mammalian AV node, including the expression of genes implicated in its development and those encoding connexins forming low conductance gap junctions. Transcriptome analysis uncovered protein-coding and noncoding transcripts enriched in AVC, which have not been previously associated with this structure, as well as dynamic expression of epithelial-to-mesenchymal transition markers and components of TGF-β, Notch, and Wnt signaling pathways likely reflecting ongoing AVC and valve development. Using transgenic line Tg(myl7:mermaid) encoding voltage-sensitive fluorescent protein, we show that abolishing the pacemaker-containing sinoatrial ring (SAR) through Isl1 loss of function resulted in spontaneous activation in the AVC region, suggesting that it possesses inherent automaticity although insufficient to replace the SAR. The SAR and AVC transcriptomes express partially overlapping species of ion channels and gap junction proteins, reflecting their distinct roles. Besides identifying conserved aspects between zebrafish and mammalian conduction systems, our results established molecular hallmarks of the developing AVC which underlies its role in structural and electrophysiological separation between heart chambers. This data constitutes a valuable resource for studying AVC development and function, and identification of novel candidate genes implicated in these processes.
Original language | English |
---|---|
Pages (from-to) | 6669-6687 |
Number of pages | 19 |
Journal | Cellular and Molecular Life Sciences |
Volume | 78 |
Issue number | 19-20 |
DOIs | |
Publication status | Published - Oct 2021 |
Bibliographical note
Funding Information:The project no. POIR.04.04.00-00-1AF0/16-00/ was carried out within the First TEAM programme of the Foundation for Polish Science co-financed by the European Union under the European Regional Development Fund. The OPUS Grants no. 2016/21/B/NZ3/00354 and 2018/29/B/NZ2/01010L from the National Science Center, Poland, supported V.K and M.P, respectively. The DIAMENTOWY scholarship from the Polish Ministry of Science and Higher Education and OPUS Grant no. 2015/19/B/NZ2/01824 from the National Science Center, Poland, supported M.L. M.M. is a recipient of the Postgraduate School of Molecular Medicine doctoral fellowship for the program “Next generation sequencing technologies in biomedicine and personalized medicine.” The Natural Sciences and Engineering Research Council of Canada (RGPIN-2016-04879), the Heart and Stroke Foundation of Canada (G-18-0022185), and the Canadian Institutes of Health Research (MOP 3425620 support T.A.Q. The British Heart Foundation (PG/14/46/30911, PG/14/83/31128), and the Magdi Yacoub Institute supported T.B. PK is a member of the Collaborative Research Centre SFB1425, funded by the German Research Foundation (#422681845).
Publisher Copyright:
© 2021, The Author(s).
ASJC Scopus Subject Areas
- Molecular Medicine
- Molecular Biology
- Pharmacology
- Cellular and Molecular Neuroscience
- Cell Biology
PubMed: MeSH publication types
- Journal Article